GPCRs constitute one of the largest classes of therapeutic targets within drug discovery. By successfully monitoring the ligand-induced dynamic mass redistribution (DMR) in living cells, this application note demonstrates that this label-free technology is a comprehensive and versatile tool for GPCR research enabling the generation of physiologically-relevant data.